SEC Comment Letter for BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818) (BPTH) — Feb 8, 2019
BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818)
Date: Feb. 8, 2019 · CIK: 0001133818 · Accession: 0000000000-19-001678
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229049
Letter
February 7, 2019 Peter H. Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Boulevard, Suite 210 Bellaire, Texas 77401 Re:Bio-Path Holdings, Inc. Registration Statement on Form S-1 Filed December 27, 2018 File No. 333-229049 Dear Mr. Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: William R. Rohrlich, II
Show Raw Text
February 7, 2019
Peter H. Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, Texas 77401
Re:Bio-Path Holdings, Inc.
Registration Statement on Form S-1
Filed December 27, 2018
File No. 333-229049
Dear Mr. Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: William R. Rohrlich, II